Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Budesonide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global Budesonide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Industry: Pharma & Healthcare
Published Date: 2026-07-08
Pages: 170 Pages
Report ld: 5557839
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Budesonide Market Size(US$)
CAGR 2026-2032
3.2%
Market Size,2032
USD 11,245
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 9,309 million
Market Forecast in 2032(Value)
US$ 11,245 million
CAGR
3.2%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Budesonide market size was US$ 8994 million in 2025 and is forecast to reach a readjusted size of US$ 11245 million by 2032 with a CAGR of 3.2% during the forecast period 2026-2032.
In 2025, global budesonide production reached approximately 600 tons, the average price is 15000 usd/kg. Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
Market Concentration and Major Players:
Internationally, the budesonide market is highly concentrated, primarily in developed countries like Europe and America. Large manufacturers include AstraZeneca and Teva. Domestically, budesonide still has significant room for growth.
Manufacturing Process and Market Trends:
The budesonide manufacturing process is divided into two ends: the active pharmaceutical ingredient (API) and the inhaled formulation. The API is primarily derived from prednisolone through five steps: esterification, defatting, oxidation, alcoholysis, and condensation. The key change in recent years—replacing the highly toxic osmium tetroxide with potassium permanganate—is cost reduction and harm mitigation. The diastereomer ratio is controlled by ketalization conditions. The core of the formulation lies not in synthesis but in micronization and suspension stabilization. The API undergoes air jet milling to control the particle size to approximately 2 micrometers to match lung deposition. The suspension is then homogenized using microfluidics and coated with phospholipids to enhance physical stability. The inhaled powder formulation requires coupling with a lactose carrier and a metering device. The aerosol formulation has completed the global transition from CFCs to HFA propellants.
In the global market, the patent for AstraZeneca's original Pulmicort expired in 2019, and generic inhalers followed suit in China and India. The demand for chronic diseases such as asthma and COPD constitutes the basic market. Colon-targeted sustained-release formulations have expanded their indications to inflammatory bowel disease, becoming a second growth curve. North America and Europe maintain their main markets due to their medical systems and payment systems. In the Asia-Pacific region, the replacement of generic drugs is accelerating due to centralized procurement and local consistency evaluation. The overall barriers are still in the registration of drug-device integrated inhalation devices and the control of micronization processes. The raw material segment has become more bulky.
The global Budesonide market is strategically segmented by company, region (country), by Dosage Form, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Dosage Form, and by Application for 2021-2032.
MARKET SEGMENTATION
By Company
- AstraZeneca (UK)
- Teva (Israel)
- Viatris (USA)
- Cipla (India)
- Cosmo Pharmaceuticals (Ireland)
- Bausch Health (Canada)
- Chiesi Farmaceutici (Italy)
- Orion Corporation (Finland)
- Axplora (France)
- Industriale Chimica (Italy)
- Aarti Pharmalabs (India)
- Sun Pharma (India)
- Vamsi Labs (India)
- Lupin (India)
- Nephron (USA)
- Takeda (Japan)
- Calliditas (Sweden)
- Dr. Falk Pharma (German)
- Padagis (USA)
- Lunan Better Pharma(China)
- Shanghai Sine Promod(China)
- Chia Tai Tianqing Pharmaceutical Group(China)
- Joincare Pharmaceutical Group Industry(China)
- Sichuan Purity Pharmaceutical(China)
- CF PharmTech(China)
- Zhejiang Furuixi Pharmaceutical(China)
- Yuanda Jiuhe (Jiangxi) Pharmaceutical(China)
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Injectable Suspension
- Aerosols
- Inhalation Powder
- Tablet and Capsule
Segment by Application
- Respiratory Disease Treatment
- Nose Disease Treatment
- Inflammatory Bowel Disease Treatment
- Others
Segment by Category
- Single-agent Budesonide
- Combination Budesonide
Segment by Division
- Budesonide API
- Budesonide Finished Dosage Form
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Dosage Form, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Budesonide sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Budesonide manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Dosage Form-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Dosage Form and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Budesonide product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Budesonide value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Budesonide Product Scope
1.2 Budesonide by Dosage Form
1.2.1 Global Budesonide Sales by Dosage Form (2021, 2025 & 2032)
1.2.2 Injectable Suspension
1.2.3 Aerosols
1.2.4 Inhalation Powder
1.2.5 Tablet and Capsule
1.3 Budesonide by Application
1.3.1 Global Budesonide Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.3.5 Others
1.4 Global Budesonide Market Estimates and Forecasts (2021-2032)
1.4.1 Global Budesonide Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Budesonide Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Budesonide Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Budesonide Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Budesonide Historical Market Scenario by Region (2021-2026)
2.2.1 Global Budesonide Sales Market Share by Region (2021-2026)
2.2.2 Global Budesonide Revenue Market Share by Region (2021-2026)
2.3 Global Budesonide Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Budesonide Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Budesonide Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Budesonide Market Size and Prospects (2021-2032)
2.4.2 Europe Budesonide Market Size and Prospects (2021-2032)
2.4.3 China Budesonide Market Size and Prospects (2021-2032)
2.4.4 Israel Budesonide Market Size and Prospects (2021-2032)
2.4.5 Japan Budesonide Market Size and Prospects (2021-2032)
2.4.6 India Budesonide Market Size and Prospects (2021-2032)
3 Global Market Size by Dosage Form
3.1 Global Budesonide Historical Market Review by Dosage Form (2021-2026)
3.1.1 Global Budesonide Sales by Dosage Form (2021-2026)
3.1.2 Global Budesonide Revenue by Dosage Form (2021-2026)
3.1.3 Global Budesonide Average Price by Dosage Form (2021-2026)
3.2 Global Budesonide Market Estimates and Forecasts by Dosage Form (2027-2032)
3.2.1 Global Budesonide Sales Forecast by Dosage Form (2027-2032)
3.2.2 Global Budesonide Revenue Forecast by Dosage Form (2027-2032)
3.2.3 Global Budesonide Price Forecast by Dosage Form (2027-2032)
3.3 Representative Players for Different Types of Budesonide
4 Global Market Size by Application
4.1 Global Budesonide Historical Market Review by Application (2021-2026)
4.1.1 Global Budesonide Sales by Application (2021-2026)
4.1.2 Global Budesonide Revenue by Application (2021-2026)
4.1.3 Global Budesonide Average Price by Application (2021-2026)
4.2 Global Budesonide Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Budesonide Sales Forecast by Application (2027-2032)
4.2.2 Global Budesonide Revenue Forecast by Application (2027-2032)
4.2.3 Global Budesonide Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Budesonide Applications
5 Competition Landscape by Players
5.1 Global Budesonide Sales by Player (2021-2026)
5.2 Global Top Budesonide Players by Revenue (2021-2026)
5.3 Global Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Budesonide revenue as of 2025
5.4 Global Budesonide Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Budesonide, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Budesonide, Product Type & Application
5.7 Global Key Manufacturers of Budesonide, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Budesonide Sales by Company
6.1.1.1 North America Budesonide Sales by Company (2021-2026)
6.1.1.2 North America Budesonide Revenue by Company (2021-2026)
6.1.2 North America Budesonide Sales Breakdown by Dosage Form (2021-2026)
6.1.3 North America Budesonide Sales Breakdown by Application (2021-2026)
6.1.4 North America Budesonide Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Budesonide Sales by Company
6.2.1.1 Europe Budesonide Sales by Company (2021-2026)
6.2.1.2 Europe Budesonide Revenue by Company (2021-2026)
6.2.2 Europe Budesonide Sales Breakdown by Dosage Form (2021-2026)
6.2.3 Europe Budesonide Sales Breakdown by Application (2021-2026)
6.2.4 Europe Budesonide Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Budesonide Sales by Company
6.3.1.1 China Budesonide Sales by Company (2021-2026)
6.3.1.2 China Budesonide Revenue by Company (2021-2026)
6.3.2 China Budesonide Sales Breakdown by Dosage Form (2021-2026)
6.3.3 China Budesonide Sales Breakdown by Application (2021-2026)
6.3.4 China Budesonide Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Israel Market: Players, Segments, Downstream and Major Customers
6.4.1 Israel Budesonide Sales by Company
6.4.1.1 Israel Budesonide Sales by Company (2021-2026)
6.4.1.2 Israel Budesonide Revenue by Company (2021-2026)
6.4.2 Israel Budesonide Sales Breakdown by Dosage Form (2021-2026)
6.4.3 Israel Budesonide Sales Breakdown by Application (2021-2026)
6.4.4 Israel Budesonide Major Customers
6.4.5 Israel Market Trends and Opportunities
6.5 Japan Market: Players, Segments, Downstream and Major Customers
6.5.1 Japan Budesonide Sales by Company
6.5.1.1 Japan Budesonide Sales by Company (2021-2026)
6.5.1.2 Japan Budesonide Revenue by Company (2021-2026)
6.5.2 Japan Budesonide Sales Breakdown by Dosage Form (2021-2026)
6.5.3 Japan Budesonide Sales Breakdown by Application (2021-2026)
6.5.4 Japan Budesonide Major Customers
6.5.5 Japan Market Trends and Opportunities
6.6 India Market: Players, Segments, Downstream and Major Customers
6.6.1 India Budesonide Sales by Company
6.6.1.1 India Budesonide Sales by Company (2021-2026)
6.6.1.2 India Budesonide Revenue by Company (2021-2026)
6.6.2 India Budesonide Sales Breakdown by Dosage Form (2021-2026)
6.6.3 India Budesonide Sales Breakdown by Application (2021-2026)
6.6.4 India Budesonide Major Customers
6.6.5 India Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 AstraZeneca (UK)
7.1.1 AstraZeneca (UK) Company Information
7.1.2 AstraZeneca (UK) Business Overview
7.1.3 AstraZeneca (UK) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.1.4 AstraZeneca (UK) Budesonide Products Offered
7.1.5 AstraZeneca (UK) Recent Development
7.2 Teva (Israel)
7.2.1 Teva (Israel) Company Information
7.2.2 Teva (Israel) Business Overview
7.2.3 Teva (Israel) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Teva (Israel) Budesonide Products Offered
7.2.5 Teva (Israel) Recent Development
7.3 Viatris (USA)
7.3.1 Viatris (USA) Company Information
7.3.2 Viatris (USA) Business Overview
7.3.3 Viatris (USA) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Viatris (USA) Budesonide Products Offered
7.3.5 Viatris (USA) Recent Development
7.4 Cipla (India)
7.4.1 Cipla (India) Company Information
7.4.2 Cipla (India) Business Overview
7.4.3 Cipla (India) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Cipla (India) Budesonide Products Offered
7.4.5 Cipla (India) Recent Development
7.5 Cosmo Pharmaceuticals (Ireland)
7.5.1 Cosmo Pharmaceuticals (Ireland) Company Information
7.5.2 Cosmo Pharmaceuticals (Ireland) Business Overview
7.5.3 Cosmo Pharmaceuticals (Ireland) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Cosmo Pharmaceuticals (Ireland) Budesonide Products Offered
7.5.5 Cosmo Pharmaceuticals (Ireland) Recent Development
7.6 Bausch Health (Canada)
7.6.1 Bausch Health (Canada) Company Information
7.6.2 Bausch Health (Canada) Business Overview
7.6.3 Bausch Health (Canada) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Bausch Health (Canada) Budesonide Products Offered
7.6.5 Bausch Health (Canada) Recent Development
7.7 Chiesi Farmaceutici (Italy)
7.7.1 Chiesi Farmaceutici (Italy) Company Information
7.7.2 Chiesi Farmaceutici (Italy) Business Overview
7.7.3 Chiesi Farmaceutici (Italy) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Chiesi Farmaceutici (Italy) Budesonide Products Offered
7.7.5 Chiesi Farmaceutici (Italy) Recent Development
7.8 Orion Corporation (Finland)
7.8.1 Orion Corporation (Finland) Company Information
7.8.2 Orion Corporation (Finland) Business Overview
7.8.3 Orion Corporation (Finland) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Orion Corporation (Finland) Budesonide Products Offered
7.8.5 Orion Corporation (Finland) Recent Development
7.9 Axplora (France)
7.9.1 Axplora (France) Company Information
7.9.2 Axplora (France) Business Overview
7.9.3 Axplora (France) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Axplora (France) Budesonide Products Offered
7.9.5 Axplora (France) Recent Development
7.10 Industriale Chimica (Italy)
7.10.1 Industriale Chimica (Italy) Company Information
7.10.2 Industriale Chimica (Italy) Business Overview
7.10.3 Industriale Chimica (Italy) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Industriale Chimica (Italy) Budesonide Products Offered
7.10.5 Industriale Chimica (Italy) Recent Development
7.11 Aarti Pharmalabs (India)
7.11.1 Aarti Pharmalabs (India) Company Information
7.11.2 Aarti Pharmalabs (India) Business Overview
7.11.3 Aarti Pharmalabs (India) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.11.4 Aarti Pharmalabs (India) Budesonide Products Offered
7.11.5 Aarti Pharmalabs (India) Recent Development
7.12 Sun Pharma (India)
7.12.1 Sun Pharma (India) Company Information
7.12.2 Sun Pharma (India) Business Overview
7.12.3 Sun Pharma (India) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.12.4 Sun Pharma (India) Budesonide Products Offered
7.12.5 Sun Pharma (India) Recent Development
7.13 Vamsi Labs (India)
7.13.1 Vamsi Labs (India) Company Information
7.13.2 Vamsi Labs (India) Business Overview
7.13.3 Vamsi Labs (India) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.13.4 Vamsi Labs (India) Budesonide Products Offered
7.13.5 Vamsi Labs (India) Recent Development
7.14 Lupin (India)
7.14.1 Lupin (India) Company Information
7.14.2 Lupin (India) Business Overview
7.14.3 Lupin (India) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.14.4 Lupin (India) Budesonide Products Offered
7.14.5 Lupin (India) Recent Development
7.15 Nephron (USA)
7.15.1 Nephron (USA) Company Information
7.15.2 Nephron (USA) Business Overview
7.15.3 Nephron (USA) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.15.4 Nephron (USA) Budesonide Products Offered
7.15.5 Nephron (USA) Recent Development
7.16 Takeda (Japan)
7.16.1 Takeda (Japan) Company Information
7.16.2 Takeda (Japan) Business Overview
7.16.3 Takeda (Japan) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.16.4 Takeda (Japan) Budesonide Products Offered
7.16.5 Takeda (Japan) Recent Development
7.17 Calliditas (Sweden)
7.17.1 Calliditas (Sweden) Company Information
7.17.2 Calliditas (Sweden) Business Overview
7.17.3 Calliditas (Sweden) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.17.4 Calliditas (Sweden) Budesonide Products Offered
7.17.5 Calliditas (Sweden) Recent Development
7.18 Dr. Falk Pharma (German)
7.18.1 Dr. Falk Pharma (German) Company Information
7.18.2 Dr. Falk Pharma (German) Business Overview
7.18.3 Dr. Falk Pharma (German) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.18.4 Dr. Falk Pharma (German) Budesonide Products Offered
7.18.5 Dr. Falk Pharma (German) Recent Development
7.19 Padagis (USA)
7.19.1 Padagis (USA) Company Information
7.19.2 Padagis (USA) Business Overview
7.19.3 Padagis (USA) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.19.4 Padagis (USA) Budesonide Products Offered
7.19.5 Padagis (USA) Recent Development
7.20 Lunan Better Pharma(China)
7.20.1 Lunan Better Pharma(China) Company Information
7.20.2 Lunan Better Pharma(China) Business Overview
7.20.3 Lunan Better Pharma(China) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.20.4 Lunan Better Pharma(China) Budesonide Products Offered
7.20.5 Lunan Better Pharma(China) Recent Development
7.21 Shanghai Sine Promod(China)
7.21.1 Shanghai Sine Promod(China) Company Information
7.21.2 Shanghai Sine Promod(China) Business Overview
7.21.3 Shanghai Sine Promod(China) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.21.4 Shanghai Sine Promod(China) Budesonide Products Offered
7.21.5 Shanghai Sine Promod(China) Recent Development
7.22 Chia Tai Tianqing Pharmaceutical Group(China)
7.22.1 Chia Tai Tianqing Pharmaceutical Group(China) Company Information
7.22.2 Chia Tai Tianqing Pharmaceutical Group(China) Business Overview
7.22.3 Chia Tai Tianqing Pharmaceutical Group(China) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.22.4 Chia Tai Tianqing Pharmaceutical Group(China) Budesonide Products Offered
7.22.5 Chia Tai Tianqing Pharmaceutical Group(China) Recent Development
7.23 Joincare Pharmaceutical Group Industry(China)
7.23.1 Joincare Pharmaceutical Group Industry(China) Company Information
7.23.2 Joincare Pharmaceutical Group Industry(China) Business Overview
7.23.3 Joincare Pharmaceutical Group Industry(China) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.23.4 Joincare Pharmaceutical Group Industry(China) Budesonide Products Offered
7.23.5 Joincare Pharmaceutical Group Industry(China) Recent Development
7.24 Sichuan Purity Pharmaceutical(China)
7.24.1 Sichuan Purity Pharmaceutical(China) Company Information
7.24.2 Sichuan Purity Pharmaceutical(China) Business Overview
7.24.3 Sichuan Purity Pharmaceutical(China) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.24.4 Sichuan Purity Pharmaceutical(China) Budesonide Products Offered
7.24.5 Sichuan Purity Pharmaceutical(China) Recent Development
7.25 CF PharmTech(China)
7.25.1 CF PharmTech(China) Company Information
7.25.2 CF PharmTech(China) Business Overview
7.25.3 CF PharmTech(China) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.25.4 CF PharmTech(China) Budesonide Products Offered
7.25.5 CF PharmTech(China) Recent Development
7.26 Zhejiang Furuixi Pharmaceutical(China)
7.26.1 Zhejiang Furuixi Pharmaceutical(China) Company Information
7.26.2 Zhejiang Furuixi Pharmaceutical(China) Business Overview
7.26.3 Zhejiang Furuixi Pharmaceutical(China) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.26.4 Zhejiang Furuixi Pharmaceutical(China) Budesonide Products Offered
7.26.5 Zhejiang Furuixi Pharmaceutical(China) Recent Development
7.27 Yuanda Jiuhe (Jiangxi) Pharmaceutical(China)
7.27.1 Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Company Information
7.27.2 Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Business Overview
7.27.3 Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Budesonide Sales, Revenue and Gross Margin (2021-2026)
7.27.4 Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Budesonide Products Offered
7.27.5 Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Recent Development
8 Budesonide Manufacturing Cost Analysis
8.1 Budesonide Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Budesonide
8.4 Budesonide Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Budesonide Distributors List
9.3 Budesonide Customers
10 Budesonide Market Dynamics
10.1 Budesonide Industry Trends
10.2 Budesonide Market Drivers
10.3 Budesonide Market Challenges
10.4 Budesonide Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Budesonide Sales (US$ Million) Growth Rate by Dosage Form (2021, 2025 & 2032)
Table 2. Global Budesonide Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)
Table 3. Global Market Budesonide Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Table 4. Global Budesonide Sales (Tons) by Region (2021-2026)
Table 5. Global Budesonide Sales Market Share by Region (2021-2026)
Table 6. Global Budesonide Revenue (US$ Million) Market Share by Region (2021-2026)
Table 7. Global Budesonide Revenue Share by Region (2021-2026)
Table 8. Global Budesonide Sales (Tons) Forecast by Region (2027-2032)
Table 9. Global Budesonide Sales Market Share Forecast by Region (2027-2032)
Table 10. Global Budesonide Revenue (US$ Million) Forecast by Region (2027-2032)
Table 11. Global Budesonide Revenue Share Forecast by Region (2027-2032)
Table 12. Global Budesonide Sales by Dosage Form (Tons) & (2021-2026)
Table 13. Global Budesonide Sales Share by Dosage Form (2021-2026)
Table 14. Global Budesonide Revenue by Dosage Form (US$ Million) & (2021-2026)
Table 15. Global Budesonide Average Price by Dosage Form (US$/kg) & (2021-2026)
Table 16. Global Budesonide Sales by Dosage Form (Tons) & (2027-2032)
Table 17. Global Budesonide Revenue by Dosage Form (US$ Million) & (2027-2032)
Table 18. Global Budesonide Average Price by Dosage Form (US$/kg) & (2027-2032)
Table 19. Representative Players of Each Type
Table 20. Global Budesonide Sales by Application (Tons) & (2021-2026)
Table 21. Global Budesonide Sales Share by Application (2021-2026)
Table 22. Global Budesonide Revenue by Application (US$ Million) & (2021-2026)
Table 23. Global Budesonide Average Price by Application (US$/kg) & (2021-2026)
Table 24. Global Budesonide Sales by Application (Tons) & (2027-2032)
Table 25. Global Budesonide Revenue Market Share by Application (US$ Million) & (2027-2032)
Table 26. Global Budesonide Average Price by Application (US$/kg) & (2027-2032)
Table 27. New Sources of Growth in Budesonide Applications
Table 28. Global Budesonide Sales by Company (Tons) & (2021-2026)
Table 29. Global Budesonide Sales Share by Company (2021-2026)
Table 30. Global Budesonide Revenue by Company (US$ Million) & (2021-2026)
Table 31. Global Budesonide Revenue Share by Company (2021-2026)
Table 32. Global Budesonide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Budesonide as of 2025)
Table 33. Global Market Budesonide Average Price by Company (US$/kg) & (2021-2026)
Table 34. Global Key Manufacturers of Budesonide, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Budesonide, Product Type & Application
Table 36. Global Key Manufacturers of Budesonide, Date of Entry into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Budesonide Sales by Company (2021-2026) & (Tons)
Table 39. North America Budesonide Sales Market Share by Company (2021-2026)
Table 40. North America Budesonide Revenue by Company (2021-2026) & (US$ Million)
Table 41. North America Budesonide Revenue Market Share by Company (2021-2026)
Table 42. North America Budesonide Sales by Dosage Form (2021-2026) & (Tons)
Table 43. North America Budesonide Sales Market Share by Dosage Form (2021-2026)
Table 44. North America Budesonide Sales by Application (2021-2026) & (Tons)
Table 45. North America Budesonide Sales Market Share by Application (2021-2026)
Table 46. Europe Budesonide Sales by Company (2021-2026) & (Tons)
Table 47. Europe Budesonide Sales Market Share by Company (2021-2026)
Table 48. Europe Budesonide Revenue by Company (2021-2026) & (US$ Million)
Table 49. Europe Budesonide Revenue Market Share by Company (2021-2026)
Table 50. Europe Budesonide Sales by Dosage Form (2021-2026) & (Tons)
Table 51. Europe Budesonide Sales Market Share by Dosage Form (2021-2026)
Table 52. Europe Budesonide Sales by Application (2021-2026) & (Tons)
Table 53. Europe Budesonide Sales Market Share by Application (2021-2026)
Table 54. China Budesonide Sales by Company (2021-2026) & (Tons)
Table 55. China Budesonide Sales Market Share by Company (2021-2026)
Table 56. China Budesonide Revenue by Company (2021-2026) & (US$ Million)
Table 57. China Budesonide Revenue Market Share by Company (2021-2026)
Table 58. China Budesonide Sales by Dosage Form (2021-2026) & (Tons)
Table 59. China Budesonide Sales Market Share by Dosage Form (2021-2026)
Table 60. China Budesonide Sales by Application (2021-2026) & (Tons)
Table 61. China Budesonide Sales Market Share by Application (2021-2026)
Table 62. Israel Budesonide Sales by Company (2021-2026) & (Tons)
Table 63. Israel Budesonide Sales Market Share by Company (2021-2026)
Table 64. Israel Budesonide Revenue by Company (2021-2026) & (US$ Million)
Table 65. Israel Budesonide Revenue Market Share by Company (2021-2026)
Table 66. Israel Budesonide Sales by Dosage Form (2021-2026) & (Tons)
Table 67. Israel Budesonide Sales Market Share by Dosage Form (2021-2026)
Table 68. Israel Budesonide Sales by Application (2021-2026) & (Tons)
Table 69. Israel Budesonide Sales Market Share by Application (2021-2026)
Table 70. Japan Budesonide Sales by Company (2021-2026) & (Tons)
Table 71. Japan Budesonide Sales Market Share by Company (2021-2026)
Table 72. Japan Budesonide Revenue by Company (2021-2026) & (US$ Million)
Table 73. Japan Budesonide Revenue Market Share by Company (2021-2026)
Table 74. Japan Budesonide Sales by Dosage Form (2021-2026) & (Tons)
Table 75. Japan Budesonide Sales Market Share by Dosage Form (2021-2026)
Table 76. Japan Budesonide Sales by Application (2021-2026) & (Tons)
Table 77. Japan Budesonide Sales Market Share by Application (2021-2026)
Table 78. India Budesonide Sales by Company (2021-2026) & (Tons)
Table 79. India Budesonide Sales Market Share by Company (2021-2026)
Table 80. India Budesonide Revenue by Company (2021-2026) & (US$ Million)
Table 81. India Budesonide Revenue Market Share by Company (2021-2026)
Table 82. India Budesonide Sales by Dosage Form (2021-2026) & (Tons)
Table 83. India Budesonide Sales Market Share by Dosage Form (2021-2026)
Table 84. India Budesonide Sales by Application (2021-2026) & (Tons)
Table 85. India Budesonide Sales Market Share by Application (2021-2026)
Table 86. AstraZeneca (UK) Company Information
Table 87. AstraZeneca (UK) Description and Business Overview
Table 88. AstraZeneca (UK) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 89. AstraZeneca (UK) Budesonide Product
Table 90. AstraZeneca (UK) Recent Development
Table 91. Teva (Israel) Company Information
Table 92. Teva (Israel) Description and Business Overview
Table 93. Teva (Israel) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 94. Teva (Israel) Budesonide Product
Table 95. Teva (Israel) Recent Development
Table 96. Viatris (USA) Company Information
Table 97. Viatris (USA) Description and Business Overview
Table 98. Viatris (USA) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 99. Viatris (USA) Budesonide Product
Table 100. Viatris (USA) Recent Development
Table 101. Cipla (India) Company Information
Table 102. Cipla (India) Description and Business Overview
Table 103. Cipla (India) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 104. Cipla (India) Budesonide Product
Table 105. Cipla (India) Recent Development
Table 106. Cosmo Pharmaceuticals (Ireland) Company Information
Table 107. Cosmo Pharmaceuticals (Ireland) Description and Business Overview
Table 108. Cosmo Pharmaceuticals (Ireland) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 109. Cosmo Pharmaceuticals (Ireland) Budesonide Product
Table 110. Cosmo Pharmaceuticals (Ireland) Recent Development
Table 111. Bausch Health (Canada) Company Information
Table 112. Bausch Health (Canada) Description and Business Overview
Table 113. Bausch Health (Canada) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 114. Bausch Health (Canada) Budesonide Product
Table 115. Bausch Health (Canada) Recent Development
Table 116. Chiesi Farmaceutici (Italy) Company Information
Table 117. Chiesi Farmaceutici (Italy) Description and Business Overview
Table 118. Chiesi Farmaceutici (Italy) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 119. Chiesi Farmaceutici (Italy) Budesonide Product
Table 120. Chiesi Farmaceutici (Italy) Recent Development
Table 121. Orion Corporation (Finland) Company Information
Table 122. Orion Corporation (Finland) Description and Business Overview
Table 123. Orion Corporation (Finland) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 124. Orion Corporation (Finland) Budesonide Product
Table 125. Orion Corporation (Finland) Recent Development
Table 126. Axplora (France) Company Information
Table 127. Axplora (France) Description and Business Overview
Table 128. Axplora (France) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 129. Axplora (France) Budesonide Product
Table 130. Axplora (France) Recent Development
Table 131. Industriale Chimica (Italy) Company Information
Table 132. Industriale Chimica (Italy) Description and Business Overview
Table 133. Industriale Chimica (Italy) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 134. Industriale Chimica (Italy) Budesonide Product
Table 135. Industriale Chimica (Italy) Recent Development
Table 136. Aarti Pharmalabs (India) Company Information
Table 137. Aarti Pharmalabs (India) Description and Business Overview
Table 138. Aarti Pharmalabs (India) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 139. Aarti Pharmalabs (India) Budesonide Product
Table 140. Aarti Pharmalabs (India) Recent Development
Table 141. Sun Pharma (India) Company Information
Table 142. Sun Pharma (India) Description and Business Overview
Table 143. Sun Pharma (India) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 144. Sun Pharma (India) Budesonide Product
Table 145. Sun Pharma (India) Recent Development
Table 146. Vamsi Labs (India) Company Information
Table 147. Vamsi Labs (India) Description and Business Overview
Table 148. Vamsi Labs (India) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 149. Vamsi Labs (India) Budesonide Product
Table 150. Vamsi Labs (India) Recent Development
Table 151. Lupin (India) Company Information
Table 152. Lupin (India) Description and Business Overview
Table 153. Lupin (India) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 154. Lupin (India) Budesonide Product
Table 155. Lupin (India) Recent Development
Table 156. Nephron (USA) Company Information
Table 157. Nephron (USA) Description and Business Overview
Table 158. Nephron (USA) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 159. Nephron (USA) Budesonide Product
Table 160. Nephron (USA) Recent Development
Table 161. Takeda (Japan) Company Information
Table 162. Takeda (Japan) Description and Business Overview
Table 163. Takeda (Japan) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 164. Takeda (Japan) Budesonide Product
Table 165. Takeda (Japan) Recent Development
Table 166. Calliditas (Sweden) Company Information
Table 167. Calliditas (Sweden) Description and Business Overview
Table 168. Calliditas (Sweden) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 169. Calliditas (Sweden) Budesonide Product
Table 170. Calliditas (Sweden) Recent Development
Table 171. Dr. Falk Pharma (German) Company Information
Table 172. Dr. Falk Pharma (German) Description and Business Overview
Table 173. Dr. Falk Pharma (German) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 174. Dr. Falk Pharma (German) Budesonide Product
Table 175. Dr. Falk Pharma (German) Recent Development
Table 176. Padagis (USA) Company Information
Table 177. Padagis (USA) Description and Business Overview
Table 178. Padagis (USA) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 179. Padagis (USA) Budesonide Product
Table 180. Padagis (USA) Recent Development
Table 181. Lunan Better Pharma(China) Company Information
Table 182. Lunan Better Pharma(China) Description and Business Overview
Table 183. Lunan Better Pharma(China) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 184. Lunan Better Pharma(China) Budesonide Product
Table 185. Lunan Better Pharma(China) Recent Development
Table 186. Shanghai Sine Promod(China) Company Information
Table 187. Shanghai Sine Promod(China) Description and Business Overview
Table 188. Shanghai Sine Promod(China) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 189. Shanghai Sine Promod(China) Budesonide Product
Table 190. Shanghai Sine Promod(China) Recent Development
Table 191. Chia Tai Tianqing Pharmaceutical Group(China) Company Information
Table 192. Chia Tai Tianqing Pharmaceutical Group(China) Description and Business Overview
Table 193. Chia Tai Tianqing Pharmaceutical Group(China) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 194. Chia Tai Tianqing Pharmaceutical Group(China) Budesonide Product
Table 195. Chia Tai Tianqing Pharmaceutical Group(China) Recent Development
Table 196. Joincare Pharmaceutical Group Industry(China) Company Information
Table 197. Joincare Pharmaceutical Group Industry(China) Description and Business Overview
Table 198. Joincare Pharmaceutical Group Industry(China) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 199. Joincare Pharmaceutical Group Industry(China) Budesonide Product
Table 200. Joincare Pharmaceutical Group Industry(China) Recent Development
Table 201. Sichuan Purity Pharmaceutical(China) Company Information
Table 202. Sichuan Purity Pharmaceutical(China) Description and Business Overview
Table 203. Sichuan Purity Pharmaceutical(China) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 204. Sichuan Purity Pharmaceutical(China) Budesonide Product
Table 205. Sichuan Purity Pharmaceutical(China) Recent Development
Table 206. CF PharmTech(China) Company Information
Table 207. CF PharmTech(China) Description and Business Overview
Table 208. CF PharmTech(China) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 209. CF PharmTech(China) Budesonide Product
Table 210. CF PharmTech(China) Recent Development
Table 211. Zhejiang Furuixi Pharmaceutical(China) Company Information
Table 212. Zhejiang Furuixi Pharmaceutical(China) Description and Business Overview
Table 213. Zhejiang Furuixi Pharmaceutical(China) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 214. Zhejiang Furuixi Pharmaceutical(China) Budesonide Product
Table 215. Zhejiang Furuixi Pharmaceutical(China) Recent Development
Table 216. Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Company Information
Table 217. Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Description and Business Overview
Table 218. Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 219. Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Budesonide Product
Table 220. Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Recent Development
Table 221. Production Base and Market Concentration Rate of Raw Material
Table 222. Key Suppliers of Raw Materials
Table 223. Budesonide Distributors List
Table 224. Budesonide Customers List
Table 225. Budesonide Market Trends
Table 226. Budesonide Market Drivers
Table 227. Budesonide Market Challenges
Table 228. Budesonide Market Restraints
Table 229. Research Programs/Design for This Report
Table 230. Key Data Information from Secondary Sources
Table 231. Key Data Information from Primary Sources
List of Figures
Figure 1. Budesonide Product Picture
Figure 2. Global Budesonide Sales (US$ Million) by Dosage Form (2021, 2025 & 2032)
Figure 3. Global Budesonide Sales Market Share by Dosage Form in 2025 & 2032
Figure 4. Injectable Suspension Product Picture
Figure 5. Aerosols Product Picture
Figure 6. Inhalation Powder Product Picture
Figure 7. Tablet and Capsule Product Picture
Figure 8. Global Budesonide Sales (US$ Million) by Application (2021, 2025 & 2032)
Figure 9. Global Budesonide Sales Market Share by Application in 2025 & 2032
Figure 10. Respiratory Disease Treatment Examples
Figure 11. Nose Disease Treatment Examples
Figure 12. Inflammatory Bowel Disease Treatment Examples
Figure 13. Others Examples
Figure 14. Global Budesonide Sales, (US$ Million), 2021 VS 2025 VS 2032
Figure 15. Global Budesonide Sales Growth Rate (2021-2032) & (US$ Million)
Figure 16. Global Budesonide Sales (Tons) Growth Rate (2021-2032)
Figure 17. Global Budesonide Price Trends Growth Rate (2021-2032) & (US$/kg)
Figure 18. Budesonide Report Years Considered
Figure 19. Global Market Budesonide Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Figure 20. Global Budesonide Revenue Market Share by Region: 2021 VS 2025
Figure 21. North America Budesonide Revenue (US$ Million) Growth Rate (2021-2032)
Figure 22. North America Budesonide Sales (Tons) Growth Rate (2021-2032)
Figure 23. Europe Budesonide Revenue (US$ Million) Growth Rate (2021-2032)
Figure 24. Europe Budesonide Sales (Tons) Growth Rate (2021-2032)
Figure 25. China Budesonide Revenue (US$ Million) Growth Rate (2021-2032)
Figure 26. China Budesonide Sales (Tons) Growth Rate (2021-2032)
Figure 27. Israel Budesonide Revenue (US$ Million) Growth Rate (2021-2032)
Figure 28. Israel Budesonide Sales (Tons) Growth Rate (2021-2032)
Figure 29. Japan Budesonide Revenue (US$ Million) Growth Rate (2021-2032)
Figure 30. Japan Budesonide Sales (Tons) Growth Rate (2021-2032)
Figure 31. India Budesonide Revenue (US$ Million) Growth Rate (2021-2032)
Figure 32. India Budesonide Sales (Tons) Growth Rate (2021-2032)
Figure 33. Global Budesonide Revenue Share by Dosage Form (2021-2026)
Figure 34. Global Budesonide Sales Share by Dosage Form (2027-2032)
Figure 35. Global Budesonide Revenue Share by Dosage Form (2027-2032)
Figure 36. Global Budesonide Revenue Share by Application (2021-2026)
Figure 37. Global Budesonide Revenue Market Share by Application in 2021 & 2025
Figure 38. Global Budesonide Sales Share by Application (2027-2032)
Figure 39. Global Budesonide Revenue Share by Application (2027-2032)
Figure 40. Global Budesonide Sales Share by Company (2025)
Figure 41. Global Budesonide Revenue Share by Company (2025)
Figure 42. Global 5 Largest Budesonide Players Market Share by Revenue in Budesonide: 2021 & 2025
Figure 43. Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 44. Manufacturing Cost Structure of Budesonide
Figure 45. Manufacturing Process Analysis of Budesonide
Figure 46. Budesonide Industrial Chain
Figure 47. Channels of Distribution (Direct Vs Distribution)
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 3.2% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Budesonide in 2026?
Which companies rank high in the global Budesonide market?
What was the global market size of Budesonide in 2032?
What is the annual compound growth rate of the global Budesonide market size from 2026 to 2032?
Related Reports
Global Budesonide Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Budesonide market is projected to grow from US$ 8994 million in 2025 to US$ 11245 million by 2032, at a CAGR of 3.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-07-08
Pages: 205
USD 4900.00
(Single User License)
Global Budesonide Market Research Report 2026
The global Budesonide market was valued at US$ 8994 million in 2025 and is anticipated to reach US$ 11245 million by 2032, at a CAGR of 3.2% from 2026 to 2032.
Published Date: 2026-07-08
Pages: 155
USD 2900.00
(Single User License)
Budesonide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Budesonide was estimated to be worth US$ 8994 million in 2025 and is projected to reach US$ 11245 million, growing at a CAGR of 3.2% from 2026 to 2032.
Published Date: 2026-07-08
Pages: 167
USD 3950.00
(Single User License)
Global Budesonide Market Report, History and Forecast 2021-2032
The global market for Budesonide was valued at US$ 8984 million in the year 2023 and is projected to reach a revised size of US$ 11165 million by 2030, growing at a CAGR of 3.2% during the forecast period 2024-2030.
Published Date: 2026-06-17
Pages: 133
USD 3350.00
(Single User License)
Global Budesonide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Budesonide market is projected to grow from US$ 8732 million in 2024 to US$ 10850 million by 2031, at a CAGR of 3.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 153
USD 4900.00
(Single User License)
Global Budesonide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Budesonide was estimated to be worth US$ 8732 million and is forecast to reach approximately US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 144
USD 5900.00
(Single User License)
Global Budesonide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Budesonide market size was US$ 8732 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 99
USD 4250.00
(Single User License)
Budesonide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Budesonide was estimated to be worth US$ 8732 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 126
USD 3950.00
(Single User License)
Global Budesonide Market Research Report 2025
The global market for Budesonide was valued at US$ 8732 million in the year 2024 and is projected to reach a revised size of US$ 10850 million by 2031, growing at a CAGR of 3.2% during the forecast period.
Published Date: 2025-01-16
Pages: 91
USD 2900.00
(Single User License)
Global Budesonide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
Published Date: 2024-04-17
Pages: 156
USD 5600.00
(Single User License)
Global Budesonide Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Budesonide market is projected to grow from US$ 8994 million in 2025 to US$ 11245 million by 2032, at a CAGR of 3.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-07-08
Pages: 205
USD 4900.00 (Single User License)Global Budesonide Market Research Report 2026
The global Budesonide market was valued at US$ 8994 million in 2025 and is anticipated to reach US$ 11245 million by 2032, at a CAGR of 3.2% from 2026 to 2032.
Published: 2026-07-08
Pages: 155
USD 2900.00 (Single User License)Budesonide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Budesonide was estimated to be worth US$ 8994 million in 2025 and is projected to reach US$ 11245 million, growing at a CAGR of 3.2% from 2026 to 2032.
Published: 2026-07-08
Pages: 167
USD 3950.00 (Single User License)Global Budesonide Market Report, History and Forecast 2021-2032
The global market for Budesonide was valued at US$ 8984 million in the year 2023 and is projected to reach a revised size of US$ 11165 million by 2030, growing at a CAGR of 3.2% during the forecast period 2024-2030.
Published: 2026-06-17
Pages: 133
USD 3350.00 (Single User License)Global Budesonide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Budesonide market is projected to grow from US$ 8732 million in 2024 to US$ 10850 million by 2031, at a CAGR of 3.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 153
USD 4900.00 (Single User License)Global Budesonide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Budesonide was estimated to be worth US$ 8732 million and is forecast to reach approximately US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 144
USD 5900.00 (Single User License)Global Budesonide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Budesonide market size was US$ 8732 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 99
USD 4250.00 (Single User License)Budesonide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Budesonide was estimated to be worth US$ 8732 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 126
USD 3950.00 (Single User License)Global Budesonide Market Research Report 2025
The global market for Budesonide was valued at US$ 8732 million in the year 2024 and is projected to reach a revised size of US$ 10850 million by 2031, growing at a CAGR of 3.2% during the forecast period.
Published: 2025-01-16
Pages: 91
USD 2900.00 (Single User License)Global Budesonide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
Published: 2024-04-17
Pages: 156
USD 5600.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now